1380331-40-7 Usage
Uses
Used in Medicinal Chemistry Research:
[1,2,4]Triazolo[1,5-a]pyridine, 7-bromo-2-(1-methylethyl)is utilized as a research compound for exploring its potential biological activities and pharmacological properties. Its unique structure and chemical properties make it a promising candidate for the development of new drugs and therapeutic agents.
Used in Drug Development:
[1,2,4]Triazolo[1,5-a]pyridine, 7-broMo-2-(1-Methylethyl)is employed as a key component in the development of new drugs, particularly in the pharmaceutical industry. Its potential applications in drug synthesis and the discovery of novel therapeutic agents are currently being investigated by researchers.
Used as a Building Block in Synthesis:
[1,2,4]Triazolo[1,5-a]pyridine, 7-bromo-2-(1-methylethyl)is used as a building block in the synthesis of other biologically active compounds. Its unique structure and properties make it a valuable component in the creation of new molecules with potential therapeutic applications.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, [1,2,4]Triazolo[1,5-a]pyridine, 7-bromo-2-(1-methylethyl)is used as a starting material for the synthesis of various drugs and pharmaceutical agents. Its potential as a precursor in the development of new medications is currently being explored by researchers and pharmaceutical companies.
Check Digit Verification of cas no
The CAS Registry Mumber 1380331-40-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,8,0,3,3 and 1 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1380331-40:
(9*1)+(8*3)+(7*8)+(6*0)+(5*3)+(4*3)+(3*1)+(2*4)+(1*0)=127
127 % 10 = 7
So 1380331-40-7 is a valid CAS Registry Number.
1380331-40-7Relevant academic research and scientific papers
TRIAZOLOPYRIDINE COMPOUNDS
-
, (2012/06/16)
The invention is concerned with triazolopyridine compounds of formula (I) wherein R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These
TRIAZOLOPYRIDINE COMPOUNDS
-
, (2012/06/30)
The invention is concerned with triazolopyridine compounds of formula (I), wherein R1, R2 , R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. The
